| 摘要 |
THE PRESENT INVENTION RELATES TO SOLID, MODIFIED-RELEASE PHARMACEUTICAL DOSAGE FORMS WHICH CAN BE ADMINISTERED ORALLY AND COMPRISE 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE, AND PROCESS FOR THEIR PRODUCTION, THEIR USE AS MEDICAMENTS, THEIR USE FOR THE PROPHYLAXIS, SECONDARY PROPHYLAXIS AND/OR TREATMENT OF DISORDERS, AND THEIR USE FOR PRODUCING A MEDICAMENT FOR THE PROPHYLAXIS, SECONDARY PROPHYLAXIS AND/OR TREATMENT OF DISORDERS.
|
